[Diagnosis and treatment of de novo malignancy after liver transplantation].
Zhu
Zhi-Jun
ZJ
Li
Lin
L
Zhang
Ya-Min
YM
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D016572:Cyclosporine / Q000009:adverse effects; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D016031:Liver Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D008875:Middle Aged; D010610:Pharyngeal Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D016019:Survival Analysis; D016559:Tacrolimus / Q000009:adverse effects; D013997:Time Factors
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D015774:Ganciclovir; D016559:Tacrolimus